中国乳腺癌中心静脉血管通路临床实践指南（2022版）

2022-01-30 中华医学会外科学分会乳腺外科学组中国实用外科杂志

中心静脉作为一种安全的输液途径已经获得共识。临床常用的中心静脉血管通路(central venous access,CVA)包括经颈内静脉、锁骨下静脉、股静脉置入的中心静脉导管(central ven

中文标题：

发布机构：

中华医学会外科学分会乳腺外科学组

发布日期：

2022-01-30

简要介绍：

中心静脉作为一种安全的输液途径已经获得共识。临床常用的中心静脉血管通路(central venous access,CVA)包括经颈内静脉、锁骨下静脉、股静脉置入的中心静脉导管(central venous catheter,CVC),经颈内静脉或锁骨下静脉的完全置入式静脉输液港,经外周静脉置入中心静脉导管(peripherally inserted central catheter,PICC)等,

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=a17791c0023a8896, title=中国乳腺癌中心静脉血管通路临床实践指南（2022版）, enTitle=, guiderFrom=中国实用外科杂志, authorId=0, author=, summary=中心静脉作为一种安全的输液途径已经获得共识。临床常用的中心静脉血管通路(central venous access,CVA)包括经颈内静脉、锁骨下静脉、股静脉置入的中心静脉导管(central ven, cover=https://img.medsci.cn/202229/1644413561903_5579292.png, journalId=0, articlesId=null, associationId=2134, associationName=中华医学会外科学分会乳腺外科学组, associationIntro=中华医学会外科学分会乳腺外科学组 , copyright=0, guiderPublishedTime=Sun Jan 30 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">中心静脉作为一种安全的输液途径已经获得共识。临床常用的中心静脉血管通路(central venous access,CVA)包括经颈内静脉、锁骨下静脉、股静脉置入的中心静脉导管(central venous catheter,CVC),经颈内静脉或锁骨下静脉的完全置入式静脉输液港,经外周静脉置入中心静脉导管(peripherally inserted central catheter,PICC)等, </span></p>, tagList=[TagDto(tagId=285, tagName=乳腺癌), TagDto(tagId=117297, tagName=妇瘤乳腺肿瘤), TagDto(tagId=122724, tagName=中心静脉血管通路)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6021, appHits=149, showAppHits=0, pcHits=716, showPcHits=5871, likes=0, shares=37, comments=3, approvalStatus=1, publishedTime=Thu Feb 10 15:29:00 CST 2022, publishedTimeString=2022-01-30, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Feb 09 21:36:27 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 18:54:38 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国乳腺癌中心静脉血管通路临床实践指南（2022版）.pdf)])

中国乳腺癌中心静脉血管通路临床实践指南（2022版）.pdf

下载请点击：

评论区 (3)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1194624, encodeId=a48e1194624a0, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210309/8cdb67009a5a436cb10e54131a6d0023/05e8b899d2b749eeb9226d900f97d5f4.jpg, createdBy=9a4e5438173, createdName=王者的眼神, createdTime=Thu Feb 17 23:03:01 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194623, encodeId=16b71194623cc, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210309/8cdb67009a5a436cb10e54131a6d0023/05e8b899d2b749eeb9226d900f97d5f4.jpg, createdBy=9a4e5438173, createdName=王者的眼神, createdTime=Thu Feb 17 23:02:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191946, encodeId=62ec119194626, content=新方法, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:27:30 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
2022-02-17 王者的眼神

厉害

93 0
[GetPortalCommentsPageByObjectIdResponse(id=1194624, encodeId=a48e1194624a0, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210309/8cdb67009a5a436cb10e54131a6d0023/05e8b899d2b749eeb9226d900f97d5f4.jpg, createdBy=9a4e5438173, createdName=王者的眼神, createdTime=Thu Feb 17 23:03:01 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194623, encodeId=16b71194623cc, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210309/8cdb67009a5a436cb10e54131a6d0023/05e8b899d2b749eeb9226d900f97d5f4.jpg, createdBy=9a4e5438173, createdName=王者的眼神, createdTime=Thu Feb 17 23:02:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191946, encodeId=62ec119194626, content=新方法, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:27:30 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
2022-02-17 王者的眼神

好的

103 0
[GetPortalCommentsPageByObjectIdResponse(id=1194624, encodeId=a48e1194624a0, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210309/8cdb67009a5a436cb10e54131a6d0023/05e8b899d2b749eeb9226d900f97d5f4.jpg, createdBy=9a4e5438173, createdName=王者的眼神, createdTime=Thu Feb 17 23:03:01 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194623, encodeId=16b71194623cc, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210309/8cdb67009a5a436cb10e54131a6d0023/05e8b899d2b749eeb9226d900f97d5f4.jpg, createdBy=9a4e5438173, createdName=王者的眼神, createdTime=Thu Feb 17 23:02:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191946, encodeId=62ec119194626, content=新方法, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:27:30 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
2022-02-10 ms3000000637975859

新方法

110 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤指南

中国乳腺癌中心静脉血管通路临床实践指南（2022版）

相关指南

科室

工具

服务